Early results from study of Gilead’s remdesivir offers ‘glimmer of hope’ in coronavirus battle

5:50am PDT - April 29th, 2020    remdesivir - The Globe And Mail

The trial was being conducted by the National Institute of Allergy and Infectious Diseases (NIAID), and more details on the data would be provided at an upcoming briefing